Increased DNA methyltransferase expression in leukaemia

Leukemia

Volumn 12, Issue 3, 1998, Pages 311-316

  Melki, J R ^a   Warnecke, P ^a   Vincent, P C ^a   Clark, S J ^a,b  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b CSIRO   (Australia)

Author keywords

Competitive RT PCR; DNA methylation; DNA methyltransferase; Leukaemia

Indexed keywords

DNA METHYLTRANSFERASE; RNA;

ACUTE LEUKEMIA; ADULT; AGED; ARTICLE; BONE MARROW; CLINICAL ARTICLE; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; FEMALE; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE;

EID: 0031907905     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2400932     Document Type: Article

References (18)

1. Holliday R. Epigenetic inheritance based on DNA methylation. In: Jost JP, Saluz HP (eds). DNA Methylation: Molecular Biology and Biological Significance. Birkhauser Verlag: Basel, 1993, pp 452-468.
2. Bestor TH. Cloning of a mammalian DNA methyltransferase. Cene 1988; 74: 9-12.
3. Gruenbaum Y, Cedar H, Razin A. Substrate and sequence specificity of a eukaryotic DNA methylase. Nature 1982; 295:620-622.
4. Bestor TH. Activation of mammalian DNA methyltransferase by cleavage of a Zn binding regulatory domain. EMBO J 1992; 11: 2611-2617.
5. Baylin SB, Makos M, Wu JJ, Yen RW, deBustros A, Vertino P, Nelkin BD. Abnormal patterns of DNA methylation in human neoplasia: potential consequences for tumor progression. Cancer Cells 1991; 3:383-390.
6. Laird PW, Jaenisch R. DNA methylation and cancer. Hum Mol Genet 1994; 3: 1487-1495.
7. Spruck C, Rideout W, Jones PA. DNA methylation and cancer. In: Jost JP, Saluz HP (eds). DNA Methylation: Molecular Biology and Biological Significance. Birkhauser Verlag: Basel, 1993, pp 487-509.
8. Yoshiura K, Kanai Y, Ochiai A, Shimoyama Y, Sugimura T, Hirohashi S. Silencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcinomas. Proc Natl Acad Sci USA 1995; 92: 7416-7419.
9. Merlo A, Herman JG, Mao L, Lee DJ, Gabrielson E, Burger PC, Baylin SB, Sidransky D. 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor P16/CDKN2/MTS1 in human cancers. Nature Med 1995; 1: 686-692.
10. Gonzalez ZM, Bender CM, Yang AS, Nguyen T, Beart RW, Van TJ, Jones PA. Methylation of the 5′ CpG island of the pi 6/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Res 1995; 55: 4531-4535.
11. Herman JG, Merlo A, Mao L, Lapidus RG, Issa JP, Davidson NE, Sidransky D, Baylin SB. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated wth aberrant DNA methylation in all common human cancers. Cancer Res 1995; 55: 4525-4530.
12. '2 Herman JG, Jen J, Merlo A, Baylin SB. Hypermethylation-associated inactivation indicates a tumor suppressor role for p15INK4B. Cancer Res 1996; 56: 722-727.
13. Kautiainen TL, Jones PA, DNA methyltransferase levels in tumori-genic and nontumorigenic cells in culture. J Biol Chem 1986; 261: 1594-1598.
14. Wu JJ, Issa JP, Herman J, Bassett DE, Nelkin BD, Baylin SB. Expression of an exogenous eukaryotic DNA methyltransferase gene induces transformation of NIH-3T3 cells. Proc Natl Acad Sci USA 1993; 90: 8891-8895.
15. Vertino PM, Yen RW, Gao J, Baylin SB. De novo methylation of CpG island sequences in human fibroblasts overexpressing DNA (cytosine-5-)-methyltransferase. Mol Cell Biol 1996; 16: 4555-4565.
16. MacLeod AR, Szyf M. Expression of antisense to DNA methyltransferase mRNA induces DNA demethylation and inhibits tumorigenesis. J Biol Chem 1995; 270: 8037-8043.
17. Laird PW, Jackson-Grusby L, Fazeli A, Dickinson SL, Jung WE, Li E, Weinberg RA, Jaenisch R. Suppression of intestinal neoplasia by DNA hypomethylation. Cell 1995; 81: 197-205.
18. Rideout WD, Coetzee GA, Olumi AF, Jones PA. 5-Methylcytosine as an endogenous mutagen in the human LDL receptor and p53 genes. Science 1990; 249: 1288-1290.